The global super-disintegrant market is projected to expand at an impressive CAGR of about 7.5% during the forecast period, 2021–2028. The growth of the market is attributed to the increasing consumption of pharmaceutical drugs by the global population.
Super-disintegrants include different kinds of integrant, which are used in the pharmaceutical business for tablet-based drug delivery. They are added to solid dosage forms such as tablets or pills to help them break when submerged in a fluid. The formation of a greater surface area of the tablets can be dissolved as they break into smaller fragments and fast drug substance is released. In spite of developing interest in various types of drugs transmission components, the method of orally transmitted drugs has not completely vanished.
Market Drivers, Restraints, Trends, and Opportunities
- Rising number of pediatric patients and the geriatric population, who are required of regular intake of various medicines are predicted to expand the market growth.
- Expansion of generic drug manufacturing is expected to exhibit a positive impact on the super-disintegrant market growth.
- Favorable regulatory standards in developed regions supporting the adoption of innovative excipients at a large scale is predicted to increase the growth of market.
- Strict regulations in the approval of drugs by several governments across various regions may hinder the growth of market during the analysis period.
- Capacity expansions of their production plants in developing countries or setting up new manufacturing plants in emerging markets such as China and India is expected to present numerous opportunities for the expansion of the market.
Scope of the Report
The report on the global super-disintegrant market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been involved in the report.
|
Attributes
|
Details
|
|
Report Title
|
Super-Disintegrant Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Types (Synthetic Super-disintegrants and Natural Super-disintegrants), Formulations (Tablets and Capsules), Therapeutic Areas (Oncology, Neurological Diseases, Inflammatory Diseases, Infectious Diseases, Hematological Diseases, Gastrointestinal Diseases, and Cardiovascular Diseases)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered
|
Roquette Frères, Merck KGaA, JRS Pharma, DowDuPont Inc., DFE Pharma, Corel Pharma Chem., BASF SE, and Ashland Global Holdings Inc.
|
Global Super-Disintegrant Market Segment Insights
In terms of types, the market is bifurcated into synthetic super-disintegrants and natural super-disintegrants. The natural super-disintegrants segment is expected to represent a key share during the forecast period due to wider research into natural super-disintegrants and its applications. Several researches have been conducted using substances such as gellan gum, locust bean gum, isapghula husk mucilage, soy polysaccharide, and karayan gum as natural substances that can function as super-disintegrants in solid dose methods. Thus, these natural super-disintegrants are anticipated to progressively find their way into the commercial space due to the positive outcomes of such studies.
On the basis of formulations, the market is bifurcated into tablets and capsules. The tablet segment is expected to constitute a large share during the forecast period due to the extensive practice of fast-disintegrating tablets and ODTs between patients and healthcare providers. This results in the wide manufacturing of these pharmaceutical products.
Based on therapeutic areas, the market is segmented into oncology, neurological diseases, inflammatory diseases, infectious diseases, hematological diseases, gastrointestinal diseases, and cardiovascular diseases. The cardiovascular diseases segment is projected to register robust growth in the coming years due to rising development of new drugs for the treatment of cardiac patients.
In terms of regions, the market is generally classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in Europe is dominating the market due to the wide research for various medicinal drugs discovery in the region. However, the market in Asia Pacific is expected to grow significantly in the coming years due to the availability of a large number of affordably priced medicinal drugs. In the super-disintegrants market, China and India have emerged as key economies that are witnessing substantial growth in pharmaceutical manufacturing in the past few years.
Segments
The global super-disintegrant market has been segmented on the basis of
Types
- Synthetic Super-disintegrants
- Natural Super-disintegrants
Formulation
Therapeutic Area
- Oncology
- Neurological Diseases
- Inflammatory Diseases
- Infectious Diseases
- Hematological Diseases
- Gastrointestinal Diseases
- Cardiovascular Diseases
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Competitive Landscape
Major players competing in the global super-disintegrant market include Roquette Frères, Merck KGaA, JRS Pharma, DowDuPont Inc., DFE Pharma, Corel Pharma Chem., BASF SE, and Ashland Global Holdings Inc.
Some of these businesses are involved in adopting numerous market strategies such as mergers, acquisitions, collaborations, partnerships, product launches, R&D activities, and capacity expansion to increase market share and global presence.
Recently, in the second quarter of fiscal year 2020, Ashland Global Holdings Inc. brought a structural change the manner in which it was handling the business. At present, it is focusing from a functionally-led organization to a business-unit focused organization.
Request For Customization
Enquiry Before Buying
Speak With Analyst
